Projects per year
Personal profile
Biography
Michael is a haematologist at Monash Health and Monash University. Michael works as a physician and pathologist. Michael additionally works in medical education. He has served as a Director of Clinical Training (DCT) at Monash Doctors Education (MDE) and currently holds the role of Director of Physician Education (DPE) at Casey Hospital.
Research interests
Michael’s research interests include myeloma and iron deficiency anaemia. He has served as the Myeloma lead at Monash Health since 2017 working closely with groups such as Myeloma Australia to provide education and support for patients. In addition, Michael is the principal investigator in over 10 completed, ongoing, and upcoming clinical trials mainly in myeloma therapy and also serves on the Australian Leukaemia and Lymphoma Group (ALLG) Myeloma working party.
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
Research area keywords
- Myeloma
- Lymphoma
- Iron deficiency
-
A Phase 1b Study of JNJ-79635322 in Combination with Daratumumab or Pomalidomide for Multiple Myeloma
Low, M. (Primary Chief Investigator (PCI))
18/12/24 → 17/12/29
Project: Research
-
A Phase 3, Multicenter, Randomized, Open Label Study of ABBV-383 Compared With Standard Available Therapies in Subjects With Relapsed or Refractory Multiple Myeloma (3L+ RRMM Monotherapy Study)
Low, M. (Primary Chief Investigator (PCI))
9/09/24 → 8/09/29
Project: Research
-
A Phase 3, Randomized, Multicentre, Open-label Study to Evaluate the Efficacy and Safety of Alnuctamab Compared to Standard of Care Regimens in Participants with Relapsed or Refractory Multiple Myeloma (RRMM)- ALUMMINATERRMM
Low, M. (Primary Chief Investigator (PCI))
22/04/24 → 21/04/29
Project: Research
-
A Phase 3, Two-stage, Randomized, Multi-center, Controlled, Open-label Study Comparing Iberdomide Maintenance to Lenalidomide Maintenance Therapy after Autologous Stem Cell Transplantation (ASCT) in Participants with Newly Diagnosed Multiple Myeloma (NDMM)
Low, M. (Primary Chief Investigator (PCI))
22/02/24 → 21/02/29
Project: Research
-
A Dose Escalation and Expansion Study of ABBV-383 in Combination with AntiCancer Regimens for the Treatment of Patients with Relapsed/Refractory Multiple Myeloma
Low, M. (Primary Chief Investigator (PCI))
3/10/22 → 2/10/27
Project: Research
-
Bilateral adrenal hemorrhage in a postpartum woman with multiple thromboemboli: a case report
Jiang, A. Y. N., Abasszade, J. H., Abrahams, T., Nan, K., Low, M. S. Y., Barnes, S. L., Lim, A. N. & Shen, J. Z. L., 25 Oct 2024, In: Journal of Medical Case Reports. 18, 7 p., 518.Research output: Contribution to journal › Article › Other › peer-review
Open Access -
Day-21 bone marrow findings incorrectly designate residual leukaemia in FLT3-mutated acute myeloid leukaemia treated with intensive induction plus midostaurin: a morphology-focused study
Tedjaseputra, A., Roy, S., Htun, K., Oh, D., McQuilten, Z., Yeh, P., Bennett, A., Yuan Low, M. S., Chunilal, S., Wood, E. M. & Shortt, J., 2024, In: Pathology. 56, 4, p. 548–555 8 p.Research output: Contribution to journal › Article › Research › peer-review
-
The prognostic impact of t(11;14) in multiple myeloma: A real‐world analysis from the Australian Lymphoma Leukaemia Group (ALLG) and the Australian Myeloma and Related Diseases Registry (MRDR)
Lim, K. J. C., Wellard, C. J., Talaulikar, D., Tan, J. L., Loh, J., Puvanakumar, P., Kuzich, J. A., Ho, M., Murphy, M. J., Zeglinas, N., Low, M. S. Y., Routledge, D., Lim, A. B. M., Gibbs, S. D. J., Quach, H., Morgan, S., Moore, E. M. & Ninkovic, S., Aug 2023, In: ejHaem. 4, 3, p. 639-646 8 p.Research output: Contribution to journal › Article › Research › peer-review
Open Access -
Concomitant diagnosis of chronic myeloid leukaemia and myeloma
Looi, W., Zargari, A., Dun, K., Grigoriadis, G., Fedele, P., Gregory, G. P. & Low, M. S. Y., Jun 2022, In: Pathology. 54, 4, p. 493-495 3 p.Research output: Contribution to journal › Letter › Other › peer-review
Open Access1 Citation (Scopus) -
COVID-19 unmasks the critical role of primary healthcare providers in the timely diagnosis of multiple myeloma
Chee, A., Low, M. S. Y., Vilcassim, S., Grigoriadis, G. & Fedele, P. L., May 2022, In: Internal Medicine Journal. 52, 5, p. 885-886 2 p.Research output: Contribution to journal › Letter › Other › peer-review
Open Access